dataesr/scientific-paragraphs-categorization huggingface dataset:
ACKNOWLEDGMENTS The authors thank the  Cellex Foundation  for providing research facilities and equipment. The breast cancer genome-wide association (BCAC) is funded by  Cancer Research UK  ( C1287/A16563 ,  C1287/ A10118 ), the  European Union 's  Horizon 2020 Research and Innovation Programme  (grant nos. 634935  and  633784  for BRIDGES and B-CAST, respectively), and by the  European Community 's  Seventh Framework Programme  under grant agreement number  223175  (grant no. HEALTH-F2-2009-223175 ) (COGS). The  EU Horizon 2020 Research and Innovation Programme  funding source had no role in study design, data collection, data analysis, data interpretation or writing of the report. Genotyping of the OncoArray was funded by the  NIH  grant  U19 CA148065 , and  Cancer UK  grant  C1287/ A16563  and the  PERSPECTIVE  project supported by the  Government of Canada through Genome Canada  and the  Canadian Institutes of Health Research  (grant  GPH-129344 ), and the  Ministère de l'Économie, Science et Innovation du Québec through Genome Québec  and the  PSRSIIRI-701  grant, and the  Quebec Breast Cancer Foundation.
Funding for the iCOGS infrastructure came from: the  European Community 's  Seventh Framework Programme  under grant agreement no. 223175  ( HEALTH-F2-2009-223175 ; COGS),  Cancer Research UK  ( C1287/A10118 ,  C1287/A10710 ,  C12292/A11174 ,  C1281/ A12014 ,  C5047/A8384 ,  C5047/A15007 ,  C5047/A10692 , and  C8197/A16565 ), the  National Institutes of Health  ( CA128978 ) and  Post-Cancer GWAS initiative  ( 1U19 CA148537 ,  1U19 CA148065 , and  1U19 CA148112 -the  GAME-ON initiative ), the  Department of Defence  ( W81XWH-10-1-0341 ), the  Canadian Institutes of Health Research (CIHR)  for the  CIHR Team in Familial Risks of Breast Cancer , and  Komen Foundation  for the Cure, the  Breast Cancer Research Foundation , and the  Ovarian Cancer Research Fund. The  DRIVE Consortium  was funded by  U19 CA148065.
M. C. S. is an  NHMRC Senior Research Fellow. The ABCS study was supported by the  Dutch Cancer Society  (grants NKI 2007-3839; 2009 4363). The  Australian Breast Cancer Tissue Bank (ABCTB)  is generously supported by the  National Health and Medical Research Council of Australia , The  Cancer Institute NSW  and the  National Breast Cancer Foundation. The ACP study is funded by the  Breast Cancer Research Trust, UK. The AHS study is supported by the intramural research program of the  National Institutes of Health , the  National Cancer Institute  (grant no. Z01-CP010119 ), and the  National Institute of Environmental Health Sciences  (grant no. Z01-ES049030 ). The work of the BBCC was partly funded by  ELAN-Fond of the University Hospital of Erlangen. The BBCS is funded by  Cancer Research UK  and  Breast Cancer Now and acknowledges NHS  funding to the  NIHR Biomedical Research Centre , and the  National Cancer Research Network (NCRN).
The BCEES was funded by the  National Health and Medical Research Council, Australia  and the  Cancer Council Western Australia  and acknowledges funding from the  National Breast Cancer Foundation (JS). For the  BCFR-NY, BCFR-PA, BCFR-UT  this work was supported by grant  UM1 CA164920  from the  National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the  National Cancer Institute  or any of the collaborating centers in the  Breast Cancer Family Registry (BCFR) , nor does mention of trade names, commercial products, or organizations imply endorsement by the  US Government  or the BCFR. For BIGGS, E. S. is supported by  NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' NHS Foundation Trust  in partnership with King's  College London, United Kingdom.
I. T. is supported by the  Oxford Biomedical Research Centre. B. O. C. S. is supported by funds from  Cancer Research UK  ( C8620/A8372/A15106 ) and the  Institute of Cancer Research (UK). B. O. C. S. acknowledges NHS funding to the  Royal Marsden/ Institute of Cancer Research NIHR Specialist Cancer Biomedical Research Centre. The  BREast Oncology GAlician Network (BREOGAN)  is funded by  Acción Estratégica de Salud del Instituto de Salud Carlos III   FIS PI12/ 02125 / Cofinanciado FEDER ;  Acción Estratégica de Salud del Instituto de Salud Carlos III FIS Intrasalud  ( PI13/ 01136 );  Programa Grupos Emergentes ,  Cancer Genetics Unit, Instituto de Investigacion Biomedica Galicia Sur. Xerencia de Xestion Integrada de Vigo-SERGAS ,  Instituto de Salud Carlos III, Spain ; Grant  10CSA012E ,  Consellería de Industria Programa Sectorial de Investigación Aplicada, PEME I + D e I + D Suma del Plan Gallego de Investigación, Desarrollo e Innovación Tecnológica de la Consellería de Industria de la Xunta de Galicia, Spain  (grant  EC11-192 ).
Fomento de la Investigación Clínica Independiente ,  Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain ; and Grant  FEDER-Innterconecta. Ministerio de Economia y Competitividad, Xunta de Galicia, Spain. The BSUCH study was supported by the  Dietmar-Hopp Foundation , the  Helmholtz Society  and the  German Cancer Research Center (DKFZ). The CAMA study was funded by  Consejo Nacional de Ciencia y Tecnología  ( CONACyT ;  SALUD-2002-C01-7462 ). Sample collection and processing were funded in part by grants from the  National Cancer Institute  ( NCI R01CA120120  and  K24CA169004 ). C. B. C. S. is funded by the  Canadian Cancer Society  (grant no. 313404 ) and the  Canadian Institutes of Health Research. C. C. G. P. is supported by funding from the  University of Crete. The CECILE study was supported by  Fondation de France ,  Institut National du Cancer (INCa) ,  Ligue Nationale Contre le Cancer ,  Agence Nationale de Sécurité Sanitaire, de l'Alimentation, de l'Environnement et du Travail (ANSES) ,  Agence Nationale de la Recherche (ANR).
The collection of cancer incidence data was supported by the  California Department of Public Health  as part of the statewide cancer reporting program mandated by  California Health and Safety Code Section 103885. HAC receives support from the  Lon V Smith Foundation  ( LVS39420 ). The University of Westminster curates the DietCompLyf database funded by  Against Breast Cancer Registered Charity  No. 1121258  and the  NCRN. The coordination of EPIC is financially supported by the  European Commission (DG-SANCO)  and the  International Agency for Research on Cancer. The national cohorts are supported by  Ligue Contre le Cancer ,  Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale ,  Institut National de la Santé et de la Recherche Médicale (INSERM) (France) ;  German Cancer Aid ,  German Cancer Research Center (DKFZ) ,  Federal Ministry of Education and Research (BMBF) (Germany) ; the  Hellenic Health Foundation , the  Stavros Niarchos Foundation (Greece) ;  Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy) ;  Dutch Ministry of Public Health, Welfare and Sports (VWS) ,  Netherlands Cancer Registry (NKR) ,  LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland) ,  World Cancer Research Fund (WCRF) ,  Statistics Netherlands  (The Netherlands);  Health Research Fund (FIS) ,  PI13/00061  to Granada,  PI13/01162  to  EPIC-Murcia, Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC  ( RD06/0020 ) (Spain);  Cancer Research UK  ( 14136  to  EPIC-Norfolk ;  C570/A16491  and  C8221/A19170  to  EPIC-Oxford ),  Medical Research Council  ( 1000143  to  EPIC-Norfolk ,  MR/M012190/1  to  EPIC-Oxford) (United Kingdom ).
The ESTHER study was supported by a grant from the  Baden Württemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study, which was supported by a grant from the  German Cancer Aid (Deutsche Krebshilfe ). FHRISK is funded from  NIHR  grant  PGfAR   0707-10031. The  GC-HBOC (German Consortium of Hereditary Breast  and  Ovarian Cancer ) is supported by the  German Cancer Aid  (grant no  110837 , coordinator:  Rita K. Schmutzler , Cologne). This work was also funded by the  European Regional Development Fund and Free State of Saxony, Germany (LIFE-Leipzig Research Centre for Civilization Diseases , project numbers  713-241202 ,  713-241202 ,  14505/ 2470 ,  14575/2470 ). The GENICA was funded by the  Federal Ministry of Education and Research (BMBF)   Germany grants   01KW9975/5 ,  01KW9976/8 ,  01KW9977/0  and  01KW0114 , the  Robert Bosch Foundation, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ) ,  Heidelberg , the  Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA) ,  Bochum , as well as the  Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.
The GEPARSIXTO study was conducted by the  German Breast Group GmbH. The GESBC was supported by the  Deutsche Krebshilfe e. V. ( 70492 ) and the  German Cancer Research Center (DKFZ). GLACIER was supported by  Breast Cancer Now, CRUK and Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The HABCS study was supported by the  Claudia von Schilling Foundation for Breast Cancer Research , by the  Lower Saxonian Cancer Society , and by the  Rudolf Bartling Foundation. The HEBCS was financially supported by the  Helsinki University Hospital Research Fund , the  Finnish Cancer Society , and the  Sigrid FENG ET AL. | 461 Juselius Foundation. The HERPACC was supported by  MEXT Kakenhi  (No. 170150181  and  26253041 ) from the  Ministry of Education, Science, Sports, Culture and Technology of Japan , by a  Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control  from  Ministry Health, Labour and Welfare of Japan , by  Health and Labour Sciences Research Grants for Research on Applying Health Technology from Ministry Health, Labour and Welfare of Japan , by  National Cancer Center Research and Development Fund, and "Practical Research for Innovative Cancer Control  ( 15ck0106177h0001 )" from  Japan Agency for Medical Research and development, AMED , and  Cancer Bio Bank Aichi.
The HMBCS was supported by a grant from the  Friends of Hannover Medical School  and by the  Rudolf Bartling Foundation. The HUBCS was supported by a grant from the  German Federal Ministry of Research and Education  ( RUS08/017 ) and by the  Russian Foundation for Basic Research  and the  Federal Agency for Scientific Organizations  for supporting the Bioresource collections and RFBR grants  14-04-97088 ,  17-29-06014 , and  17-44-020498. ICICLE was supported by  Breast Cancer Now, CRUK and Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. Financial support for KAR-BAC was provided through the regional agreement on medical training and clinical research (ALF) between  Stockholm County Council and Karolinska Institutet , the  Swedish Cancer Society , The Gustav V Jubilee foundation and Bert von Kantzows foundation.
The KARMA study was supported by  Märit and Hans Rausings Initiative Against Breast Cancer. The KBCP was financially supported by the special Government Funding (EVO) of  Kuopio University Hospital  grants,  Cancer Fund of North Savo , the  Finnish Cancer Organizations , and the strategic funding of the  University of Eastern Finland. The kConFab  Follow-Up Study  is supported by grants from  Cancer Australia , the  Australian National Breast Cancer Foundation , the  National Health and Medical Research Council , the  National Institute of Health USA , the  Queensland Cancer Fund , the  Cancer Councils of New South Wales, Victoria , Tasmania and  South Australia , and the  Cancer Foundation of Western Australia. KAP is an  Australian National Breast Cancer Foundation Practitioner Fellow. Financial support for the AOCS was provided by the  United States Army Medical Research and Materiel Command  ( DAMD17-01-1-0729 ),  Cancer Council Victoria, Queensland Cancer Fund, Cancer Council New South Wales, Cancer Council South Australia , The  Cancer Foundation of Western Australia, Cancer Council Tasmania  and the  National Health and Medical Research Council of Australia (NHMRC ;  400413 ,  400281 , and  199600 ).
L. M. B. C. is supported by the  "Stichting tegen Kanker. "D. L. is supported by the  FWO. The MABCS study is funded by the  Research Centre for Genetic Engineering  and  Biotechnology "Georgi D. Efremov " and supported by the  German Academic Exchange Program ,  DAAD. The MARIE study was supported by the  Deutsche Krebshilfe e. V. ( 70-2892-BR I, 106332 ,  108253 ,  108419 ,  110826 ,  110828 ), the  Hamburg Cancer Society , the  German Cancer Research Center (DKFZ)  and the  Federal Ministry of Education and Research (BMBF) Germany  ( 01KH0402 ). MBCSG is supported by grants from the  Italian Association for Cancer Research (AIRC)  and by funds from the  Italian  citizens who allocated the 5/1,000 share of their tax payment in support of the  Fondazione IRCCS Istituto Nazionale Tumori , according to Italian laws ( INT-Institutional strategic  projects "5 × 1,000").
The MCBCS was supported by the  NIH  grants  CA192393 ,  CA116167 ,  CA176785 , and  NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer  ( CA116201 ), and the  Breast Cancer Research Foundation  and a generous gift from the  David F. and Margaret T. Grohne Family Foundation. The Melbourne Collaborative Cohort Study (MCCS) cohort recruitment was funded by  VicHealth  and  Cancer Council Victoria. The MCCS was further augmented by  Australian National Health and Medical Research Council  grants  209057 ,  396414 , and  1074383  and by infrastructure provided by  Cancer Council Victoria. Cases and their vital status were ascertained through the  Victorian Cancer Registry  and the  Australian Institute of Health and Welfare , including the  National Death Index  and the  Australian Cancer Database.
"The MEC was supported by  NIH  grants  CA63464 ,  CA54281 ,  CA098758 ,  CA132839 , and  CA164973. The MISS study is supported by funding from  ERC -2011-294576 Advanced grant,  Swedish Cancer Society, Swedish Research Council, Local hospital funds, Berta Kamprad Foundation ,  Gunnar Nilsson. The MMHS study was supported by  NIH  grants  CA97396 ,  CA128931 , Data on SCCS cancer cases from Mississippi were collected by the  Mississippi Cancer Registry which participates in the National Program of Cancer Registries (NPCR)  of the  Centers for Disease Control and Prevention (CDC). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the  Mississippi Cancer Registry. SEARCH is funded by  Cancer Research UK  ( C490/A10124  and  C490/A16561 ) and supported by the  UK National Institute for Health Research Biomedical Research Centre  at the  University of Cambridge.
The  University of Cambridge  has received salary support for PDPP from the  NHS in the East of England through the Clinical Academic Reserve. SEBCS was supported by the  BRL (Basic Research Laboratory ) program through the  National Research Foundation of Korea  funded by the  Ministry of Education, Science and Technology  ( 2012-0000347 ). SGBCC is funded by the  NUS start-up Grant, National University Cancer Institute Singapore (NCIS)   Centre Grant  and the  NMRC Clinician Scientist Award. Additional controls were recruited by the  Singapore Consortium of Cohort Studies-Multi-ethnic cohort (SCCS-MEC ), which was funded by the  Biomedical Research Council , grant no. 05/1/21/19/425. The Sister Study (SISTER) is supported by the  Intramural Research Program  of the  NIH, National Institute of Environmental Health Sciences  ( Z01-ES044005  and  Z01-ES049033 ).
The  Two Sister Study  ( 2SISTER ) was supported by the  Intramural Research Program  of the  NIH, National Institute of Environmental Health Sciences  ( Z01-ES044005  and  Z01-ES102245 ), and, also by a grant from  Susan G. Komen for the Cure , grant  FAS0703856. SKKDKFZS is supported by the  DKFZ. The SMC is funded by the  Swedish Cancer Foundation. The SZBCS and IHCC were supported by Grant  PBZ_KBN_ 122/P05/2004  and the program of the  Minister of Science and Higher Education  under the name " Regional Initiative of Excellence " in 2019-2022 project number  002/ RID/2018/19  amount of financing 12, 000 , 000 PLN. The TBCS was funded by The  National Cancer Institute of Thailand. The TNBCC was supported by a  Specialized Program of Research Excellence (SPORE) in Breast Cancer  ( CA116201 ), a grant from the  Breast Cancer Research Foundation , a generous gift from the  David F.
and Margaret T. Grohne Family Foundation. The TWBCS is supported by the  Taiwan Biobank  project of the  Institute of Biomedical Sciences, Academia Sinica, Taiwan. The UCIBCS component of this research was supported by the  NIH  ( CA58860  and  CA92044 ) and the  Lon V Smith Foundation  ( LVS39420 ). The UKBGS is funded by  Breast Cancer Now  and the  Institute of Cancer Research (ICR) ,  London  and also thank the study participants, study staff, and the doctors, nurses and other health care providers and health information sources who have contributed to the study. ICR acknowledges NHS funding to the  NIHR Biomedical Research Centre. The UKOPS study was funded by  The Eve Appeal (The Oak Foundation ) and supported by the  National Institute for Health Research University College London Hospitals Biomedical Research Centre.
The US3SS study was supported by Massachusetts (K. M. E. ,  R01CA47305 ),  Wisconsin  (P. A. N. ,  R01 CA47147 ), and  New Hampshire  (L. T. -E. , R01CA69664) centers, and  Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The  USRT Study  was funded by  Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The WAABCS study was supported by grants from the  National Cancer Institute of the National Institutes of Health  ( R01 CA89085  and  P50 CA125183  and the  D43 TW009112  grant),  Susan G. Komen  ( SAC110026 ),  Dr. Ralph and Marian Falk Medical Research Trust , and the  Avon Foundation for Women. The  WHI program  is funded by the  National Heart, Lung, and Blood Institute , the  US National Institutes of Health  and the  US Department of Health and Human Services  ( HHSN268201100046C ,  HHSN268201 100001C ,  HHSN268201100002C ,  HHSN268201100003C ,  HHSN268201100004C , and  HHSN271201100004C ).
This work was also funded by  NCI   U19 CA148065-01. D. G. E. is supported by the all Manchester  NIHR Biomedical research center Manchester  ( IS-BRC-1215-20007 ). HUNBOCS,  Hungarian Breast , and  Ovarian Cancer Study  were supported by  Hungarian Research Grant   KTIA-OTKA CK-80745 ,  NKFI_OTKA K-112228. C. I. received support from the  Survey, Recruitment , and  Biospecimen Shared Resource at Georgetown University  ( NIH/NCI P30-CA-51008 ) and the  Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research. K. M. is supported by  CRUK   C18281/A19169. City of Hope Clinical Cancer Community Research Network  and the  Hereditary Cancer Research Registry , supported in part by Award Number  RC4CA153828  (PI:  J Weitzel ) from the  National Cancer Institute  and the office of the Director,  National Institutes of Health.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The ICO study is supported by the  Asociación Española Contra el Cáncer (AECC) ,  The Instituto de Salud Carlos III (organismo adscrito al Ministerio de Economía y Competitividad)  and  "Fondo Europeo de Desarrollo Regional (FEDER) , una manera de hacer Europa" ( PI10/01422 ,  PI13/00285 ,  PIE13/ 00022 ,  PI15/00854 ,  PI16/00563 , and CIBERONC) and  The Institut Català de la Salut and Autonomous Government of Catalonia  ( 2009SGR290 ,  2014SGR338  and  PERIS Project MedPerCan ). Dr. Beth Karlan  is funded by the  American Cancer Society Early Detection Professorship  ( SIOP-06-258-01-COUN ) and the  National Center for Advancing Translational Sciences (NCATS) , grant  UL1TR000124.
A. V. is supported by the  Spanish Health Research Foundation ,  Instituto de Salud Carlos III (ISCIII) , partially supported by  FEDER  funds through  Research Activity Intensification Program  (contract grant nos. INT15/ 00070 ,  INT16/00154 ,  INT17/00133 ), and through  Centro de Investigación Biomédica en Red de Enferemdades Raras CIBERER  ( ACCI 2016: ER17P1AC7112/2018 );  Autonomous Government of Galicia  (Consolidation and structuring program:  IN607B ), and by the  Fundación Mutua Madrileña  (call 2018). The GEMO resource was initially funded by the  French National Institute of Cancer (INCa ,  PHRC Ile de France , grant  AOR 01 082 ,  2001-2003 , grant  2013-1-BCB-01-ICH-1 ), the Association "Le cancer du sein, parlons-en!" Award (2004) the  Association for International Cancer Research  ( 2008-2010 ), and the  Fondation ARC pour la recherche sur le cancer  (grant  PJA 20151203365 ).
It also received support from the  Canadian Institute of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program  ( 2008-2013 ), and the European commission  FP7 ,  Project «Collaborative Ovarian , breast and prostate Gene-environment Study (COGS), Large-scale integrating project» (2009-2013). G. E. M. O. is currently supported by the  INCa  grant  SHS-E-SP 18-015. OSUCCC was funded by the  Ohio State University Comprehensive Cancer Center. Leigha Senter ,  Kevin Sweet ,  Caroline Craven ,  Julia Cooper ,  Amber Aielts , and  Michelle O'Conor  aided in the recruitment of BRCA1/2 study participants and data collection. Robert Pilarski  aided in recruitment and data collection of TNBC cases from the  Stefanie Spielman Breast Bank. Clinical Genetics Branch ,  NCI : the  Intramural Research Program  of the  US National Cancer Institute, NIH, Division of Cancer Epidemiology and Genetics , and by support services contracts  NO2-CP-11019-50 ,  N02-CP-21013-63  and  N02-CP-65504  with  Westat, Inc ,  Rockville, MD.
DATA AVAILABILITY STATEMENT The GWAS summary data that support the findings of overall, ER-, ER+ breast cancer results are openly available in the Breast Cancer Association Consortium (BCAC). The GWAS summary data that support the findings of caseonly breast cancer results will also be made available at the BCAC website. http://bcac. ccge. medschl. cam. ac. uk/ bcacdata/oncoarray/gwas-icogs-and-oncoarray-summaryresults/ (Michailidou et al. , 2017, pp. 92-94).
We address four questions: what kinds of actions do the public take; how does engagement change over time; what does a typical engagement journey look like; and what factors drive engagement with development organisations? To address these questions, we draw on new panel data from the Aid Attitudes Tracker, 2013-18 (AAT). The AAT explores public attitudes and behavioural engagement with global poverty in four major donor countries: France, Germany, Britain, and the US. We introduce a new set of measures of actions the public take to engage with international development, comprising 18 different indicators. From these, we use latent class analysis to provide the first large-scale segmentation of public engagement with global poverty. We show how the five engagement groups -"Totally Disengaged", "Marginally Engaged", "Informationally Engaged", "Behaviourally Engaged", and "Fully Engaged"move over time, illustrating the most common engagement journeys across the four countries, and explore the drivers of change that influence these.